Stay updated on Tempol (MBM-02) in COVID-19 Patients Clinical Trial

Sign up to get notified when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing all participating states. Removed separate per-state location sections and the HHS Vulnerability Disclosure link.
    Difference
    1%
    Check dated 2025-12-23T21:06:37.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; no user-visible changes to the study details or page layout were detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:39:13.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Deletion of the government funding notice about potential delays in website updates and responses. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:53:36.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The screenshots show the same study page with no substantive changes to core content.
    Difference
    0.4%
    Check dated 2025-11-03T20:54:54.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    - Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T05:07:19.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Apparent page reversion to a new version (v3.1.0) while removing several drug-safety and drug-category topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating content consolidation.
    Difference
    0.5%
    Check dated 2025-09-29T02:55:41.000Z thumbnail image

Stay in the know with updates to Tempol (MBM-02) in COVID-19 Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.